Patent · US Active

Immunoglobulin fusion proteins and uses thereof

US11820807B2 · kind B2 · utility

0Cited by
10References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 9, 2016
Grant dateNov 21, 2023
Priority date
Expiry dateJun 9, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N9/644
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

A fusion protein is disclosed. The fusion protein of the invention comprises an Fc fragment of an immunoglobulin G and a bioactive molecule, wherein the Fc is a single chain Fc. The amino acids in the hinge of the Fc is mutated, substituted, or deleted so that the hinge of Fc cannot form disulfide bonds. Methods for producing and using the fusion protein of the invention are also provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.